These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 740305)

  • 1. [Nephrological experiences in the treatment of urinary infections by fosfomycin].
    Mioli V; Figus S
    Minerva Med; 1978 Dec; 69(59):4093-6. PubMed ID: 740305
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antibacterial activity of fosfomycin in chronic kidney infections].
    Schena FP; Selvaggi FP; Montagna MT; Salvatore C
    Minerva Med; 1978 Dec; 69(59):4097-104. PubMed ID: 105327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fosfomycin. Controlled clinical studies.
    Rodriguez A; Olay T; Vicente MV; Oliver LE
    G Ital Chemioter; 1977; 23(2):127-32. PubMed ID: 342325
    [No Abstract]   [Full Text] [Related]  

  • 4. [Fosfomycin in the treatment of some infectious diseases].
    Aceti A; Vullo V; Ferone U; Delia S
    Clin Ter; 1979 Jan; 88(1):61-6. PubMed ID: 436378
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of amikacin in renal pathology].
    Triolo G; Mangiarotti G; Pacitti A; Jeantet A; Paola M; Messina M; Cardelli R; Randone DF; Porcellini G; Martini PF; Segoloni GP
    Minerva Urol; 1981; 33(1):27-32. PubMed ID: 7242506
    [No Abstract]   [Full Text] [Related]  

  • 6. [Use of fosfomycin in antibiotic therapy. Its effectiveness in patients with acute renal insufficiency or on hemodialysis treatment].
    Rossi R; Colantonio G; Fraticelli M; Giura C; Quarenghi MI; Polli O; Ferradini MA; Nonini MO
    G Ital Chemioter; 1979; 26(1-2):315-7. PubMed ID: 554823
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical experiments in the use of fosfomycin in oral microbial infections].
    Quaranta M
    Dent Cadmos; 1983 Mar; 51(3):57-64. PubMed ID: 6576933
    [No Abstract]   [Full Text] [Related]  

  • 8. ZTI-01 (fosfomycin for injection) in the treatment of hospitalized patients with complicated urinary tract infections.
    Burgos RM; Rodvold KA
    Future Microbiol; 2019 Apr; 14():461-475. PubMed ID: 30854892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study and use of fosfomycin in the clinical field].
    Azzaroli P; de Martinis E; Zoli F; Garoia C
    G Ital Chemioter; 1978; 25(1):1-4. PubMed ID: 376386
    [No Abstract]   [Full Text] [Related]  

  • 10. [Fosfomycin in severe infection in neonatology].
    Rossignol S; Regnier C
    Ann Pediatr (Paris); 1984 May; 31(5):437-44. PubMed ID: 6742722
    [No Abstract]   [Full Text] [Related]  

  • 11. [Fosfomycin in a hematology department].
    Dinelli CA; Montrasio PL; Tansini G
    Minerva Med; 1978 Dec; 69(59):4111-4. PubMed ID: 740308
    [No Abstract]   [Full Text] [Related]  

  • 12. [Fosfomycin in urogenital infections. Experimental assumptions and clinical results].
    Savoia D; Fontana G; Laudi M; Cauda F
    Minerva Med; 1978 Dec; 69(59):4087-91. PubMed ID: 740304
    [No Abstract]   [Full Text] [Related]  

  • 13. [Fosfomycin. II. Antimicrobial activity in vivo].
    Carlone NA; Cuffini AM; Savoia D
    G Batteriol Virol Immunol; 1977; 70(7-12):215-25. PubMed ID: 615746
    [No Abstract]   [Full Text] [Related]  

  • 14. Fosfomycin in paediatric cancer patients: a feasible alternative to glycopeptides?
    Hepping N; Simon A
    Int J Antimicrob Agents; 2009 Apr; 33(4):389. PubMed ID: 19097756
    [No Abstract]   [Full Text] [Related]  

  • 15. A multicenter, randomized parallel double-blind study comparing three antibiotics, cephemic-cofosfolactamine, fosfomycin and cephalexin, in the treatment of systemic infections.
    Mangini P; Cicchetti M; Bottaro L; Messina V; Brancadoro MT; Puppo F
    Chemioterapia; 1985 Jun; 4(3):222-6. PubMed ID: 4028283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of metronidazole and fosfomycin alone and in combination in the treatment of experimentally induced intra-abdominal infections.
    Nord CE; Lahnborg G
    Scand J Gastroenterol Suppl; 1984; 90():15-9. PubMed ID: 6588479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of cofosfolactamine in localized bacterial infections].
    Scalzini A; Chiodera A; Sueri L
    G Ital Chemioter; 1984; 31(1-2):205-6. PubMed ID: 6468828
    [No Abstract]   [Full Text] [Related]  

  • 18. [Revival of selected well-tried antibiotics. Special features of the antiinfective agents penicillin G, fosfomycin, aztreonam and colistin].
    Lipp HP
    Med Monatsschr Pharm; 2012 Oct; 35(10):367-77. PubMed ID: 23094579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Further experiences with gentamicin].
    Pardelli G
    G Ital Chemioter; 1969; 16(1):202-4. PubMed ID: 5404098
    [No Abstract]   [Full Text] [Related]  

  • 20. Antibiotic resistance and pyelonephritis.
    Foxman B; Ki M; Brown P
    Clin Infect Dis; 2007 Aug; 45(3):281-3. PubMed ID: 17599304
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.